Instrumental secured US$20 million in Series B financing in the middle of 2020 to accelerate development of its manufacturing optimization platform (see the ABI Insight “Manufacturing Optimization Systems for the Postmodern COVID-19 Era”). Since then, the company has built new software features and achieved a twofold increase in customers, revenue, and headcount.
You must be a subscriber to view this ABI Insight.
To find out more about subscribing contact a representative about purchasing options.